International Clinical Cytometry Society

Nonprofit profile at a glance

EIN
264251596
IRS 990 coverage
2011–2025
Forms available
Form 990 2025, Form 990-EZ 2010
Location
Glenview, IL, USA
Phone
8479833519
Rating
69
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Single Organization Support

Official website

Reported finances

Revenue
$683,469
Expenses
$869,361
Assets
$780,042
Liabilities
$40,170

Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

15 people listed

Executive titles in this filing

  • Sa Wang MD (Past President)
  • Jolene Cardinali MT ASCP (Vice President)
  • Wolfgang Kern MD (President)

People named in this filing

  • Sa Wang MD (Past President)
  • Amanda Fultz (Council Member)
  • Alan Dunlop MSc (Sr. Councilor)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Primary objectives and purposes are to foster the development and implementation of clinical applications of cytometry in the diagnosis and management of human pathologic conditions; to stimulate and promote research in new applications of cytometry and allied disciplines; to promote professional advancement in all aspects of clinical cytometry and to foster education and the exchange of information among persons engaged in clinical cytometry by means of an annual national meeting and of a variety of educational activities; to issue publications in the field of clinical cytometry and its applications; to interact with agencies, both private and governmental, which regulate, oversee, monitor and control the practice of clinical cytometry, in the interest and for the benefit of clinical cytometry, and the patients it serves.

What it reported doing in 2025

Sponsored the 40th annual Clinical Cytometry Meeting and Educational Course virtually and on-site in Philadelphia, PA.The course/meeting is designed for Laboratory Directors, Physicians, Laboratory Managers and Supervisors, Clinical Laboratory Scientists/Medical Technologists, and Residents/Fellows. The goals of these events are to help participants increase their knowledge of current tools and technologies available for patient sample analysis, better understand the accepted methodologies and benchmarks for patient sample analysis and diagnosis, and to increase their competence in using analytical software applications.

Operating model

Revenue model
Earned-program. 65% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 99% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and most voting board members are independent. The filing reports few safeguards for money sent abroad and the filing does not identify recipients for some grant dollars.

Rating breakdown

  • Financial Efficiency: 86
  • Transparency & Controls: 47
  • Accountability: 70
  • Sustainability: 28
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 100%; rating input score 100
  • Program expense ratio: 89.6%; rating input score 90
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 81.8%; rating input score 82; 1st percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Scored; rating input score 0
  • Grant itemization coverage: 0%; rating input score 0; 15th percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 2 of 7 controls in place; rating input score 29
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: -27.2%; rating input score 5; 5th percentile among comparable filings
  • Total-asset coverage ratio: 0.9; rating input score 40; 40th percentile among comparable filings
  • Liabilities to assets ratio: 0.05; rating input score 43; 43rd percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 78; 78th percentile among comparable filings

Growth

  • Program expense growth: 4.8% per year; rating input score 100; 35th percentile among comparable filings
  • Revenue growth: 2% per year; rating input score 100; 19th percentile among comparable filings
  • Asset growth: 2.9% per year; rating input score 100; 26th percentile among comparable filings

Details

  • Where the money goes: 100% of revenue deployed · 89.6% of spending went to programs
  • Governance: 15 of 15 board members independent · 2 of 7 filing controls reported
  • Programs: 3 filed program accomplishments · $779K in reported program spending
  • Leadership: top reported pay $0 · 15 people listed
  • Highest-paid contractors: 1 contractor listed · $177K reported
  • Consistency: 17 of 18 current checks pass · 1 finding to review
  • Schedules: 4 filed schedules · includes major donors and foreign activity
  • Filing history: 15 filing years from 2011 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Transparency & Controls: Foreign activity oversight scored 0/100.
  • High — Transparency & Controls: Grant itemization coverage scored 0/100.
  • High — Accountability: Governance controls: 4 of 6 not reported.
  • High — Sustainability: Operating margin scored 5/100.
  • Moderate — Sustainability: Total-asset coverage ratio scored 40/100.
  • Moderate — Transparency & Controls: Schedule A contributions reconciliation did not reconcile in the filed values.
  • Moderate — Sustainability: Liabilities to assets ratio scored 43/100.